Journal of Health Care and Research · Mar 6, 2026
Larger Relationship Between Diabetes and Alzheimer Disease and Related Dementias (ADRD)
By Bando H, Urasaki H, Bando M et al.
Patients with Alzheimer disease and related dementias (ADRD) tend to develop diabetes more than those without diabetes. Diabetic treatments mainly include DPP4-i, GLP-1RAs, and SGLT2-i. They are reported to decrease neuroinflammation, amyloid beta accumulation, and hyperphosphorylation of tau protein, and to prevent neuronal loss and enhance neurogenesis. Anti-diabetic agents may decrease dementia risk in T2D based on large research data of 4 million individuals. As a result, the odds ratios (OR) for reducing dementia showed SGLT2-i 0.69, GLP-1RA 0.70, DPP4-i 0.86, metformin 0.92, sulfonylurea 1.02, α-GI 1.14, and insulin 1.26. From some studies, GLP-1RAs and SGLT2-i show a similar degree of clinical effect.